I-MAB (IMAB) Long-Term Capital Lease Obligation : $3.24 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is I-MAB Long-Term Capital Lease Obligation?

I-MAB's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.24 Mil.

I-MAB's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($4.60 Mil) to Jun. 2023 ($2.85 Mil) but then increased from Jun. 2023 ($2.85 Mil) to Dec. 2023 ($3.24 Mil).

I-MAB's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($12.84 Mil) to Dec. 2022 ($4.60 Mil) and declined from Dec. 2022 ($4.60 Mil) to Dec. 2023 ($3.24 Mil).

I-MAB Long-Term Capital Lease Obligation Historical Data

The historical data trend for I-MAB's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

I-MAB Long-Term Capital Lease Obligation Chart

I-MAB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.07

0.85

12.84

4.60

3.24

I-MAB Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial								12.84	9.16	4.60	2.85	3.24

I-MAB (NAS:IMAB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

I-MAB Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of I-MAB's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

I-MAB (IMAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » I-MAB (NAS:IMAB) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

0VY:Germany

Address

555 West Haiyang Road, 55th Floor, New Bund Center, Pudong District, Shanghai, CHN, 200124

Website

https://www.i-mabbiopharma.com

I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will likely be eftansomatropin, a long-acting growth hormone that has a large market in China among pediatric patients with short stature, which we estimate will launch in 2024 or 2025. Other core assets include lemzoparlimab, a potential best-in-class CD47 inhibitor in phase 2 trials; uliledlimab, a potential best-in-class CD73 inhibitor in phase 2 trials; and felzartamab for the Chinese market, a CD38 inhibitor for multiple myeloma, which could have a phase 3 data readout in 2023.